— Know what they know.
Not Investment Advice

CDAK NASDAQ

Codiak BioSciences, Inc.
1W: +33.3% 1M: +58.7% 3M: -96.5% 1Y: -99.4%
$0.06
Last traded 2023-05-23 — delisted
NASDAQ · Healthcare · Biotechnology

Balance Sheet Trends

Total Assets
$172M +13.4% ▲
3Y CAGR: +20.7%
Total Liabilities
$118M -13.6% ▼
3Y CAGR: +175.9%
Shareholders Equity
$54M +267.3% ▲
3Y CAGR: -16.5%
Cash & Investments
$77M -13.5% ▼
3Y CAGR: -4.7%
Total Debt
$63M -0.0% ▼
Net Debt
-$14M +46.2% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2018FY2019FY2020FY2021
— Assets —
Cash$18M$10M$89M$77M
Short-Term Investments$71M$73M$0$0
Cash & ST Investments$89M$83M$89M$77M
Net Receivables$0$6M$0$0
Inventory$0$2M$0$0
Other Current Assets$2M$3M$5M$13M
Total Current Assets$91M$94M$94M$90M
Property, Plant & Equip.$6M$18M$53M$45M
Goodwill & Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Other Non-Current Assets$693K$4M$4M$36M
Total Non-Current Assets$7M$22M$58M$81M
Total Assets$98M$116M$151M$172M
— Liabilities —
Accounts Payable$615K$2M$2M$2M
Short-Term Debt$0$0$1M$3M
Deferred Revenue$0$742K$5M$13M
Other Current Liabilities$4M$17M$9M$10M
Total Current Liabilities$5M$20M$18M$27M
Long-Term Debt$0$10M$62M$60M
Other Non-Current Liab.$732K$10M$207K$0
Total Non-Current Liabilities$732K$74M$119M$91M
Total Liabilities$6M$94M$137M$118M
— Equity —
Common Stock$0$0$2K$2K
Retained Earnings-$109M-$193M-$288M-$325M
Accumulated OCI-$9K$43K-$151M$0
Total Stockholders Equity$92M$22M$15M$54M
Total Liabilities & Equity$98M$116M$151M$172M
— Key Metrics —
Total Debt$0$10M$63M$63M
Net Debt-$18M-$744K-$26M-$14M
Total Investments$71M$73M$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms